Functional testing methods for the antiplatelet effects of aspirin | Biomarkers in Medicine
Aspirin antiplatelet effects are associated with body weight - ScienceDirect
Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients | Arteriosclerosis, Thrombosis, and Vascular Biology
Antithrombotic therapies (Chapter 18) - The Stroke Book
Antiplatelet Therapy in Acute Coronary Syndrome | ECR Journal
Antiplatelet drugs (antithrombotics)
Antiplatelet drugs (antithrombotics)
Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke
Low-Dose Aspirin for the Prevention of Atherothrombosis | NEJM
Table 3 from Platelet testing to guide aspirin dose adjustment in pediatric patients after cardiac surgery | Semantic Scholar
Dose- and time-dependent antiplatelet effects of aspirin Christina Perneby, N. Håkan Wallén, Cathy Rooney, Desmond Fitzgerald, Paul Hjemdahl Published. - ppt download
Early Aspirin Discontinuation After Coronary Stenting: A Systematic Review and Meta‐Analysis | Journal of the American Heart Association
Antiplatelet Therapy | Thoracic Key
Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovasc
The art of delivering evidence-based dual antiplatelet therapy | MDedge Family Medicine
Antiplatelet therapy in acute coronary syndrome - Brown - 2017 - Continuing Cardiology Education - Wiley Online Library
Pharmacokinetics of antiplatelet drugs. | Download Table
Frontiers | Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review
Aspirin as an Antiplatelet Drug | NEJM
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials - The Lancet
Aspirin Continues to Attract Research and Debate, 115 Years After Its Synthesis | Revista Española de Cardiología
Davide Capodanno on Twitter: "Secondary prevention with antithrombotic strategies that are not limited to aspirin monotherapy is an emerging paradigm. After excluding features of a high bleeding risk, patients with additional risk
Role of aspirin in primary prevention of cardiovascular disease | Nature Reviews Cardiology
Comparison of studies in terms of dosing of antiplatelet drugs during... | Download Scientific Diagram
Doses of antiplatelet co-therapies | Download Table
